BUTRYBIOM Trademark

Trademark Overview


On Monday, March 30, 2026, a trademark application was filed for BUTRYBIOM with the United States Patent and Trademark Office. The USPTO has given the BUTRYBIOM trademark a serial number of 99733230. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 30, 2026. This trademark is owned by Biom Pharmaceutical Corporation. The BUTRYBIOM trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Active chemical ingredients for use in the manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Cancer; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Inflammatory Bowel Disorder

Dietary supplements; Probiotic supplements; Nutritional supplements; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Dietary fiber for use as an ingredient in the manufacture of dietary supplements
butrybiom

General Information


Serial Number99733230
Word MarkBUTRYBIOM
Filing DateMonday, March 30, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, March 30, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Cancer; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Inflammatory Bowel Disorder
Goods and ServicesDietary supplements; Probiotic supplements; Nutritional supplements; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Dietary fiber for use as an ingredient in the manufacture of dietary supplements
Pseudo MarkBUTTERY BIOME
Pseudo MarkBUTRY BIOME

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, March 30, 2026
Primary Code001
First Use Anywhere DateWednesday, December 3, 2025
First Use In Commerce DateTuesday, December 16, 2025

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 30, 2026
Primary Code005
First Use Anywhere DateWednesday, December 3, 2025
First Use In Commerce DateWednesday, March 25, 2026

Trademark Owner History


Party NameBiom Pharmaceutical Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSarasota, FL 34243
US

Trademark Events


Event DateEvent Description
Monday, March 30, 2026NEW APPLICATION ENTERED
Monday, March 30, 2026APPLICATION FILING RECEIPT MAILED